Mesa Laboratories, Inc.

NASDAQ:MLAB

Hardware, Equipment & Parts

Technology
$137.81 -0.16%

-$0.15 today

Market cap
$774.56M
Beta
0.93
P/E (TTM)
78.3
EPS (TTM)
$1.21
Dividend yield
0.68%
52W Low $55.45High $113.99

Volume 0.07M

Average 0.16M

MLAB EBITDA Margin

EBITDA as a percentage of revenue.

Mesa Laboratories, Inc.NASDAQ: MLAB

EBITDA Margin · Q4 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 6.5%

EBITDA Margin was 6.5% in Q4 FY2026, down 10.3 pp from a year earlier. On a trailing-twelve-month basis it was 17.4%, up 0.1 pp year over year. Over 3 fiscal years it narrowed by 3.0 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 43.5% for the fiscal year ending Mar 2027, up from 14.2% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
6.5%-14.0 pp QoQ
Last fiscal yearMar 2026
14.2%-3.4 pp YoY
LTMMar 2026
17.4%+0.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-10.3 pp+19.1 pp+29.5 pp
1 year-3.4 pp+29.4 pp+32.8 pp
3 years-3.0 pp——
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2026
14.2%
Year-over-year change
-3.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How MLAB compares with its peers on the latest reported figures

  • MLAB's LTM Mar 2026 EBITDA Margin of 17.4% is the 7th highest of the 11 companies compared; the peer median is 21.8%.
  • Its year-over-year change of +0.1 pp is the 6th highest of 11, against a peer median of -0.2 pp.
  • Over three fiscal years its change of -3.0 pp compares with a peer median of -1.1 pp.
MLAB Competitors Peer median
EBITDA Margin for MLAB and competitors
Company Period LTM level YoY 3-year change
QGENQiagen N.V.LTM Jun 202633.5% -1.6 pp-2.1 pp
AAgilent Technologies, Inc.LTM Jul 202627.6% +1.1 pp-1.4 pp
TECHBio-Techne CorporationLTM Sep 202626.8% +8.6 pp-11.9 pp
RVTYRevvity, Inc.LTM Jul 202626.3% -3.0 pp-8.9 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202623.7% -2.2 pp-0.9 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202619.9% -6.2 pp+208.5 pp
MLABMesa Laboratories, Inc.LTM Mar 202617.4% +0.1 pp-3.0 pp
TXG10x Genomics, Inc.LTM Sep 20266.1% +10.9 pp+25.5 pp
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026-26.6% +89.9 pp-148.5 pp
PACBPacific Biosciences of California, Inc.LTM Mar 2026-66.6% +85.7 pp+198.6 pp
LABStandard BioTools Inc.LTM Mar 2026-94.5% -30.2 pp+72.1 pp
Peer median (excluding MLAB) 21.8%-0.2 pp-1.1 pp

Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue184.34M219.08M216.19M240.98M249.13M
Cost of Revenue75.25M85.39M82.94M90.11M90.86M
Gross Profit109.09M133.69M133.25M150.87M158.27M
Gross Margin59.2%61.0%61.6%62.6%63.5%
Research & Development15.77M20.49M19.3M19.52M20.31M
Selling, General & Admin88.62M109.88M111.49M115.02M119.45M
Operating Expenses104.39M130.37M405.33M134.53M139.76M
Depreciation & Amortization25.07M33.13M31.57M24.53M23.27M
EBITDA32.53M37.52M(238.38M)42.35M35.29M
EBITDA Margin17.6%17.1%-110.3%17.6%14.2%
Operating Income4.7M3.32M(272.08M)16.34M18.51M
Operating Margin2.6%1.5%-125.9%6.8%7.4%
Interest Income00000
Interest Expense3.89M4.77M5.7M11.86M10.69M
Other Income / Expenses(1.13M)(3.71M)(3.57M)(10.38M)(6.5M)
Income Before Tax3.57M(389K)(275.65M)5.96M12.01M
Pre-Tax Margin1.9%-0.2%-127.5%2.5%4.8%
Income Tax Expense1.7M(1.32M)(21.4M)7.94M5.3M
Net Income1.87M930K(254.25M)(1.97M)6.71M
Net Margin1.0%0.4%-117.6%-0.8%2.7%
EPS (Basic)0.360.17(47.20)(0.36)1.22
EPS (Diluted)0.350.17(47.20)(0.36)1.21
Weighted Avg Shares5.21M5.32M5.39M5.43M5.51M
Weighted Avg Shares (Diluted)5.34M5.36M5.39M5.43M5.57M

Mesa Laboratories, Inc.

NASDAQ:MLAB

Intrinsic Alpha fair value

Locked

Current Price

$137.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.